ACHE and Alzheimer disease: Taken together, the in vitro results indicate that the KBD possesses multimodes of action against multiple targets in the AD pathological cascade including: (a) antioxidant, (b) anti-AChE, (c) anti-Aβ aggregation, (d) neuroprotection, and (e) anti-apoptosis.